We adjusted travel costs for inflation in the future using GDP Deflator projections. We modelled future estimates for parameters with no existing long-term projections. These are annual wages, obesity ...

An ideal inhibitor would be a non-covalent, reversible inhibitor with excellent selectivity, good bioavailability and no side effects ... which is encouraging for the future.